Missing content? – Request curation!
Request curation for specific Genes, variants, or PubMed publications.
Have questions, comments or suggestions? - Let us know!
Email us at : firstname.lastname@example.org
AGL2043 inhibits the tyrosine kinase activity of PDGFRA, PDGFRB, KIT, and FLT3, which may inhibit growth and promote apoptosis in cancer (PMID: 12670652).
|DrugClasses||FLT3 Inhibitor 55 KIT Inhibitor 51 PDGFR Inhibitor (Pan) 27|
|CAS Registry Number||22617-28-8|
|Therapy Name||Drugs||Efficacy Evidence||Clinical Trials|